Judges at this year’s International Pharmaceutical Expo 2017 (INTERPHEX) have hailed Watson-Marlow Fluid Technology Group’s Quantum peristaltic pump as ‘cutting-edge’ at this year’s INTERPHEX Exhibitor Awards.
As winner of the Best Technological Innovation category, the Quantum peristaltic pump with patented ReNu SU Technology cartridge has been recognized as: ‘a technology with the potential to change the way pharmaceutical and biotech companies operate.’
Sponsored by Pharmaceutical Processing magazine, the INTERPHEX awards are widely recognized as a leading event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge.
Launched at INTERPHEX in March, Quantum offers a step change in pump technology for bioprocessing, enabling higher downstream process yields throughout the pressure range and exceeding the performance of any other pump available. Its patented single-use technology provides exceptional downstream process performance, delivering higher yields and improved flow linearity throughout the 3 bar pressure range. Quantum outperforms any other bioprocessing pump available, with ultra-low shear and a class leading 4000:1 turn down ratio.
Commenting on the award win, Steve Lavargna, Sales and Marketing Director at Watson-Marlow Fluid Technology Group comments:
“When we designed Quantum, we wanted to redefine peristaltic pump performance for single-use downstream bioprocessing. We are very confident that this has been achieved. However, to have achieved external recognition from respected industry peers and experts is fantastic news on two levels. Firstly, it is well deserved by Quantum’s product development team – all of whom have worked so hard. Secondly, from a customer perspective, the award offers an additional layer of market confidence and advocacy in our leading-edge technology.”
The judges on this year’s Exhibitor Awards panel were Andrew Berg, Editorial Director, Pharmaceutical Processing; David Hall, Vice President of Sales, Parenteral Drug Association (PDA), Christa Myers, Associate/Senior Pharmaceutical Engineering Specialist, CRB; Matthew vonEsch, Senior Director, Manufacturing, Exelead; Gil Roth, Founder and President, Pharma & Biopharma Outsourcing Association (PBOA); Barry Holtz, Principal, Holtz Biopharma Consulting and Eric Jayjock, PhD, Director of Continuous Manufacturing, Patheon.
INTERPHEX represents the future of pharmaceutical, biotech and device development and manufacturing innovation, offering access to new business trends and strategies, cutting-edge technical sessions and state-of-the-art technologies, products and services to reduce costs, increase productivity and maximize efficiency. INTERPHEX took place March 21-23, 2017 at the Javits Center in New York.
About Watson-Marlow Fluid Technology Group
Watson-Marlow Fluid Technology Group (WMFTG) is the world leader in niche peristaltic pumps and associated fluid path technologies. Founded on nearly 60 years of supplying engineering and process expertise and with over one million pumps installed worldwide, our pumps are tried, tested and proven to deliver.
WMFTG is a wholly owned subsidiary of Spirax-Sarco Engineering plc (LSE: SPX), a global organisation employing approximately 4,800 people worldwide. Watson-Marlow Fluid Technology Group comprises ten established brands, each with their own area of expertise, but together offering our customers an unrivalled breadth of solutions for their pumping applications:
- Watson-Marlow Pumps: peristaltic tube pumps for biopharm and process industries
- Watson-Marlow Tubing: precision tubing for pumping and other purposes, in a range of materials
- Bredel: high flow, heavy duty hose pumps
- Alitea: unique peristaltic solutions for OEM customers
- Flexicon: aseptic filling and capping systems
- MasoSine: gentle sinusoidal pumps for food, chemical and cosmetics applications
- BioPure: advanced single-use tubing connector systems
- ASEPCO: aseptic valves for the biopharmaceutical industry